These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 31061250)

  • 1. Therapy-related Secondary Malignancy After Treatment of Childhood Malignancy: Cases from a Single Center.
    Ueda T; Migita M; Itabashi T; Tanabe Y; Uchimura R; Gocho Y; Yamanishi M; Kobayashi F; Yoshino M; Fujita A; Yamanishi S; Kaizu K; Hayakawa J; Asano T; Maeda M; Itoh Y
    J Nippon Med Sch; 2019 Sep; 86(4):207-214. PubMed ID: 31061250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Second malignancies after Ewing's sarcoma: radiation dose-dependency of secondary sarcomas.
    Kuttesch JF; Wexler LH; Marcus RB; Fairclough D; Weaver-McClure L; White M; Mao L; Delaney TF; Pratt CB; Horowitz ME; Kun LE
    J Clin Oncol; 1996 Oct; 14(10):2818-25. PubMed ID: 8874344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High incidence of meningioma in cranial irradiated survivors of childhood acute lymphoblastic leukemia.
    Goshen Y; Stark B; Kornreich L; Michowiz S; Feinmesser M; Yaniv I
    Pediatr Blood Cancer; 2007 Sep; 49(3):294-7. PubMed ID: 17243137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cumulative incidence of secondary neoplasms as a first event after childhood acute lymphoblastic leukemia.
    Hijiya N; Hudson MM; Lensing S; Zacher M; Onciu M; Behm FG; Razzouk BI; Ribeiro RC; Rubnitz JE; Sandlund JT; Rivera GK; Evans WE; Relling MV; Pui CH
    JAMA; 2007 Mar; 297(11):1207-15. PubMed ID: 17374815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secondary Acute Leukemia in Sarcoma Patients: A Population-Based Study.
    Sanford NN; Martin AM; Brunner AM; Cote GM; Choy E; DeLaney TF; Aizer AA; Chen YL
    Int J Radiat Oncol Biol Phys; 2018 Mar; 100(3):687-694. PubMed ID: 29413281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longitudinal follow-up of adult survivors of Ewing sarcoma: A report from the Childhood Cancer Survivor Study.
    Marina NM; Liu Q; Donaldson SS; Sklar CA; Armstrong GT; Oeffinger KC; Leisenring WM; Ginsberg JP; Henderson TO; Neglia JP; Stovall MA; Yasui Y; Randall RL; Geller DS; Robison LL; Ness KK
    Cancer; 2017 Jul; 123(13):2551-2560. PubMed ID: 28222219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Childhood ALL and second neoplasms.
    Maniar TN; Braunstein I; Keefe S; Hussen S; Abrams T; De Michele A; El-Deiry WS
    Cancer Biol Ther; 2007 Oct; 6(10):1525-31. PubMed ID: 17952026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secondary hematopoietic malignancies in survivors of childhood cancer: an analysis of 111 cases from the Surveillance, Epidemiology, and End Result-9 registry.
    Rihani R; Bazzeh F; Faqih N; Sultan I
    Cancer; 2010 Sep; 116(18):4385-94. PubMed ID: 20549819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiation-induced meningiomas: a shadow in the success story of childhood leukemia.
    Banerjee J; Pääkkö E; Harila M; Herva R; Tuominen J; Koivula A; Lanning M; Harila-Saari A
    Neuro Oncol; 2009 Oct; 11(5):543-9. PubMed ID: 19179425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Second malignancies after treatment for Ewing's sarcoma: a report of the CESS-studies.
    Dunst J; Ahrens S; Paulussen M; Rübe C; Winkelmann W; Zoubek A; Harms D; Jürgens H
    Int J Radiat Oncol Biol Phys; 1998 Sep; 42(2):379-84. PubMed ID: 9788419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of Meningioma in European Patients Treated With Growth Hormone in Childhood: Results From the SAGhE Cohort.
    Swerdlow AJ; Cooke R; Beckers D; Butler G; Carel JC; Cianfarani S; Clayton P; Coste J; Deodati A; Ecosse E; Hokken-Koelega ACS; Khan AJ; Kiess W; Kuehni CE; Flück CE; Pfaffle R; Sävendahl L; Sommer G; Thomas M; Tidblad A; Tollerfield S; Zandwijken GRJ
    J Clin Endocrinol Metab; 2019 Mar; 104(3):658-664. PubMed ID: 30137467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Second Malignant Neoplasms in Childhood Cancer Survivors Treated in a Tertiary Paediatric Oncology Centre.
    Lim JW; Yeap FS; Chan YH; Yeoh AE; Quah TC; Tan PL
    Ann Acad Med Singap; 2017 Jan; 46(1):11-19. PubMed ID: 28182813
    [No Abstract]   [Full Text] [Related]  

  • 13. Morbidity and Mortality Associated With Meningioma After Cranial Radiotherapy: A Report From the Childhood Cancer Survivor Study.
    Bowers DC; Moskowitz CS; Chou JF; Mazewski CM; Neglia JP; Armstrong GT; Leisenring WM; Robison LL; Oeffinger KC
    J Clin Oncol; 2017 May; 35(14):1570-1576. PubMed ID: 28339329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of benign meningioma after childhood cancer in the DCOG-LATER cohort: contributions of radiation dose, exposed cranial volume, and age.
    Kok JL; Teepen JC; van Leeuwen FE; Tissing WJE; Neggers SJCMM; van der Pal HJ; Loonen JJ; Bresters D; Versluys B; van den Heuvel-Eibrink MM; van Dulmen-den Broeder E; van der Heiden-van der Loo M; Aleman BMP; Daniels LA; Haasbeek CJA; Hoeben B; Janssens GO; Maduro JH; Oldenburger F; van Rij C; Tersteeg RJHA; Hauptmann M; ; Kremer LCM; Ronckers CM
    Neuro Oncol; 2019 Feb; 21(3):392-403. PubMed ID: 30099534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of subsequent malignancies in survivors of childhood leukemia.
    Perkins SM; Dewees T; Shinohara ET; Reddy MM; Frangoul H
    J Cancer Surviv; 2013 Dec; 7(4):544-50. PubMed ID: 23749687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Second malignant neoplasms after treatment of childhood acute lymphoblastic leukemia.
    Schmiegelow K; Levinsen MF; Attarbaschi A; Baruchel A; Devidas M; Escherich G; Gibson B; Heydrich C; Horibe K; Ishida Y; Liang DC; Locatelli F; Michel G; Pieters R; Piette C; Pui CH; Raimondi S; Silverman L; Stanulla M; Stark B; Winick N; Valsecchi MG
    J Clin Oncol; 2013 Jul; 31(19):2469-76. PubMed ID: 23690411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Temporal Trends in Treatment and Subsequent Neoplasm Risk Among 5-Year Survivors of Childhood Cancer, 1970-2015.
    Turcotte LM; Liu Q; Yasui Y; Arnold MA; Hammond S; Howell RM; Smith SA; Weathers RE; Henderson TO; Gibson TM; Leisenring W; Armstrong GT; Robison LL; Neglia JP
    JAMA; 2017 Feb; 317(8):814-824. PubMed ID: 28245323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-Term Risk of Subsequent Malignant Neoplasms After Treatment of Childhood Cancer in the DCOG LATER Study Cohort: Role of Chemotherapy.
    Teepen JC; van Leeuwen FE; Tissing WJ; van Dulmen-den Broeder E; van den Heuvel-Eibrink MM; van der Pal HJ; Loonen JJ; Bresters D; Versluys B; Neggers SJCMM; Jaspers MWM; Hauptmann M; van der Heiden-van der Loo M; Visser O; Kremer LCM; Ronckers CM;
    J Clin Oncol; 2017 Jul; 35(20):2288-2298. PubMed ID: 28530852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Second malignancy after treatment of childhood non-Hodgkin lymphoma.
    Leung W; Sandlund JT; Hudson MM; Zhou Y; Hancock ML; Zhu Y; Ribeiro RC; Rubnitz JE; Kun LE; Razzouk B; Evans WE; Pui CH
    Cancer; 2001 Oct; 92(7):1959-66. PubMed ID: 11745271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Second cancers in long-term survivors of Ewing's sarcoma.
    Smith LM; Cox RS; Donaldson SS
    Clin Orthop Relat Res; 1992 Jan; (274):275-81. PubMed ID: 1729013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.